Who owns the PHENHANCE trademark?

The PHENHANCE trademark is owned by Martek Pharmacal Co..

What class is the PHENHANCE trademark registered in?

The PHENHANCE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for PHENHANCE?

The USPTO serial number for PHENHANCE is 88402107.

What is the registration number for PHENHANCE?

PHENHANCE is registered under USPTO registration number 5998456.

Sealvo

Home Search: PHENHANCEPHENHANCE #88402107

Back

Updated Sep 19, 2026·34 searches this week

View on USPTO TSDR Find similar marks

PHE

USPTO Trademark Record

REGISTERED

PHENHANCE

SN 88402107·Reg 5998456·Filed Apr 25, 2019

Owner Martek Pharmacal Co.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

PHENHANCE (Serial No. 88402107), Registration No. 5998456, is a registered US trademark filed on Apr 25, 2019 by Martek Pharmacal Co.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: February 25, 2030

Conflict Analysis

Full conflict analysis for PHENHANCE (SN 88402107) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

PHENHANCE (Reg. #5998456) is a registered US trademark that has been protecting its owner, Martek Pharmacal Co., since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 25, 2019

SERIAL

88402107

REG#

5998456

REGISTERED

Feb 25, 2020

Filing Information

StatusREGISTERED

Filing DateApr 25, 2019

Serial Number88402107

Registration No.5998456

Registration DateFeb 25, 2020

Status DateNov 21, 2025

Published for OppositionAug 13, 2019

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedSection 15 AcknowledgedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: May 13, 2019

First use in commerce: May 13, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Nov 21, 2025

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Nov 21, 2025

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 17, 2025

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Jul 31, 2025

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 25, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 25, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 21, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 18, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

ASSIGNED TO LIE

Jan 17, 2020

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 17, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 17, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 03, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Dec 19, 2019

SU - NON-FINAL ACTION - WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 19, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Dec 19, 2019

NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Dec 13, 2019

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 13, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 06, 2019

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 06, 2019

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 08, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 13, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 13, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 24, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 10, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jul 08, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 10, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 29, 2019

NEW APPLICATION ENTERED

Other Marks by Martek Pharmacal Co.

Additional USPTO filings from the same owner.

CEL

CELL PRESS

76697951

Martek Pharmacal Co.

REGISTERED

Other Marks by Anthony Wilkinson

Additional USPTO filings handled by the same attorney of record.

LOG

LogoMark

86587906

REGISTERED

REL

RELUVNATION

99428858

REGISTERED

DOM

DOMINATE 365

98584352

REGISTERED

FIR

FIRSTTECH

98779915

REGISTERED

PHENHANCE

Run a conflict check

Other Marks by Martek Pharmacal Co.

Other Marks by Anthony Wilkinson

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company